Brief Title
National Longitudinal Cohort of Hematological Diseases
Official Title
National Longitudinal Cohort of Hematological Diseases (NICHE)
Brief Summary
Background Hematological diseases are disorders of the blood and hematopoietic organs. The current hematological cohorts are mostly based on single-center or multi-center cases, or cohorts with limited sample size in China. There is a lack of comprehensive and large-scale prospective cohort studies in hematology. The purpose of this study is to analyze the incidence and risk factors of major blood diseases, the treatment methods, prognosis and medical expenses of these patients in China. Method The study will include patients diagnosed with acute myeloid leukemia, multiple myeloma, or hemophilia in the investigating hospitals from January 1, 2020, and collect basic information, diagnostic and treatment information, as well as medical expense information from medical records. The study will use questionnaire to measure the exposure of patients, and prospectively follow-up to collect the prognosis information.
Study Type
Observational
Primary Outcome
Incidence and distribution
Secondary Outcome
Therapeutic evaluation
Condition
Multiple Myeloma
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Estimated Enrollment
2300
Start Date
December 1, 2020
Completion Date
December 1, 2030
Primary Completion Date
December 1, 2025
Eligibility Criteria
Inclusion Criteria: - Patients who were diagnosed with acute myeloid leukemia, multiple myeloma or hemophilia in the investigating hospitals from January 1, 2020. Exclusion Criteria: - Long-term follow-up information for patients is not available for any reason, such as not being available or having a serious concomitant disease. - Alcohol and drug addictions affect their ability to comply with study requirements. - According to the investigator, there are conditions that may endanger the patient's safety or affect his/her compliance.
Gender
All
Ages
N/A - N/A
Accepts Healthy Volunteers
No
Contacts
, +86 02223909051, [email protected]
Administrative Informations
NCT ID
NCT04645199
Organization ID
IHBDH-IIT2020025
Responsible Party
Principal Investigator
Study Sponsor
Institute of Hematology & Blood Diseases Hospital
Study Sponsor
, ,
Verification Date
November 2020